Global ursodiol is forecast to 10.41% over the next five years. According to the WK-chem Research, “Global Ursodiol Professional Survey Report 2022, Forecast to 2027”, the market is projected to expand due to the high frequency of illnesses such as gallstones and liver cirrhosis. The compound annual growth rate (CAGR) for the 2022-2027 period is projected to be 10.41% base on WK-chem Research regression analysis model.

Analysts’ Viewpoint:
“The number of patients and prevalence of primary biliary cholangitis, the chronic cholestatic liver disease is increasing, with the majority of patients treated with ursodiol medical therapy, thus driving demand for the ursodiol market”, said Adam Roberts, Senior analyst, in WK-chem Research.

Market insight:
Cholestatic liver diseases are at the forefront of driving demand in the global ursodiol market. Rising instances of gall stones and cystic fibrosis is in large part responsible for driving the market. Certain side effects of UDCA, on the other hand, are preventing the ursodiol market from achieving its full potential.

Competition Landscape:
This WK-chem Research market report is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading ursodiol companies that include: ICE, Mitsubishi Tanabe Pharma, Daewoong Chemical, PharmaZell GmbH, Zhangshanbelling, Dipharma Francis, Grindeks, Erregierre, Abil Chempharma, Biotavia Labs, Suzhou Tianlu, Arcelor Chemicals.

Segmentation of Ursodiol Market:
According to the type, the market for ursodiol is divided into: extraction ursodiol and synthetic ursodiol. Synthetic ursodiol has the largest market share. The synthetic acid is widely used in the treatment of gallstones and is marketed under multiple trade names such as Actibile, Actigall, Ursolic, Ursofalk, and Steiner.
According to the application, the market for ursodiol is divided into: pharmacy and health products. Health products has the largest market share. The end-products in health products come in the form of tablets and capsules which are marketed by pharmaceutical companies as alternatives to the surgical procedure of gallstones operation.

Ursodiol Market: Regional Analysis
In terms of geography, the global ursodiol market has been segmented into: North America, Asia Pacific, Europe, South America, and the Middle East and Africa. The Asia-Pacific region is the leading geographical segment by market revenue owing to the rise in production and product sales of the end-products in leading countries such as China and Japan.

Cagr: 10.41%
Largest share area：Asia Pacific

Largest share country：China
Product Type：Extraction Ursodiol and Synthetic Ursodiol.
Application：Pharmacy and Health Products.
Leading Company：ICE, Mitsubishi Tanabe Pharma, Daewoong Chemical, PharmaZell GmbH, Zhangshanbelling